Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01709019
What this trial is testing

RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly

Who this might be right for
Respiratory Syncytial Virus (RSV)
Novavax 220
Early research (Phase 1)WithdrawnNCT01797419
What this trial is testing

Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus Infections
Gilead Sciences
Not applicableActive Not RecruitingNCT07816471
What this trial is testing

RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsImmunocompromised HostInfluenza+1 more
Hospital Italiano de Buenos Aires 350
Not applicableLooking for participantsNCT04743609
What this trial is testing

RSV Burden in Outpatient and Hospital Settings

Who this might be right for
RSV InfectionChildren, OnlyOutpatient+1 more
Association Clinique Thérapeutique Infantile du val de Marne 1,900
Large-scale testing (Phase 3)Ended earlyNCT00031473
What this trial is testing

Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT05900154
What this trial is testing

Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age

Who this might be right for
RESPIRATORY SYNCYTIAL VIRUS (RSV)
Pfizer 128
Not applicableStudy completedNCT05506670
What this trial is testing

Disease Burden of RSV

Who this might be right for
RSV Acute Respiratory Infection
Hospices Civils de Lyon 84
Early research (Phase 1)Study completedNCT01968083
What this trial is testing

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 51
Testing effectiveness (Phase 2)Ended earlyNCT03572062
What this trial is testing

Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Who this might be right for
Respiratory Tract Infection
Pfizer 317
Not applicableWithdrawnNCT01098227
What this trial is testing

Exhaled Nitric Oxide Levels in Infants and Young Children Infected With RSV or Other Viral Infections

Who this might be right for
BronchiolitisInfectionNitric Oxide
NYU Langone Health
Not applicableUnknownNCT05348655
What this trial is testing

Impact of the Covid-19 on RSV Epidemic in the Metropolis of Lyon

Who this might be right for
RhinovirusRSV Infection in Children Less Than 5 Years of Age
Hospices Civils de Lyon 600
Early research (Phase 1)Study completedNCT01905215
What this trial is testing

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 128
Not applicableStudy completedNCT07177508
What this trial is testing

First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Viral (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Prevention
Nicola Irwin 2,355
Testing effectiveness (Phase 2)Study completedNCT03379675
What this trial is testing

Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 72
Not applicableActive Not RecruitingNCT05913700
What this trial is testing

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)

Who this might be right for
Respiratory Syncytial Virus (RSV)Respiratory Viral InfectionAcute Disease
Institute for Clinical Effectiveness, Japan 3,067
Not applicableStudy completedNCT04782336
What this trial is testing

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test

Who this might be right for
Covid19RSV InfectionInfluenza Type A+1 more
LumiraDx UK Limited 79
Testing effectiveness (Phase 2)Study completedNCT00496821
What this trial is testing

Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus

Who this might be right for
Respiratory Syncytial Virus Infections
Alnylam Pharmaceuticals 88
Testing effectiveness (Phase 2)Study completedNCT02673476
What this trial is testing

A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus

Who this might be right for
Respiratory Syncytial Virus Infections
Alios Biopharma Inc. 9
Not applicableNot Yet RecruitingNCT07015255
What this trial is testing

Assessing the Burden of Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionAcute Lower Respiratory Tract InfectionsBronchiolitis+2 more
Abu Dhabi Health Services Company 1,500
Testing effectiveness (Phase 2)Ended earlyNCT03656510
What this trial is testing

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 246
Next Page